VerifiedBiotechnology Research· Founded 2016

Immunic Therapeutics

Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/

7-day free trial · no credit card

New York City, United States83(51 to 200)2016imux.com LinkedIn

Verified contacts

available on Kipplo

LinkedIn employees

51 to 200 range

Open roles

—

no listings

Distinct roles

indexed titles

Tech stack

tools in use

Monthly traffic

608

organic / mo

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

67 contacts with verified email or phone · masked until revealed.

TT
Tamara Tahlov
Executive Assistant Office Manager · Operations
EmailPhone
JM
James Myles
Global Head of Biostatistics · Other
EmailPhone
FG
Fereshteh Ghadiri
Medical Director · Research & Development
EmailPhone
IS
Inderpal Singh
General Counsel · Legal
EmailPhone
JB
Jessica Breu
Vice President Investor Relations and Communications · Finance & Accounting
EmailPhone
RA
Roman Austermayer
Vice President Finance · Finance & Accounting
EmailPhone
AF
Anna Frey
Manager, Cmc · General Business & Management
EmailPhone
CB
Christian Biberger
Global Clinical Operations Program Lead · Healthcare & Human Services
EmailPhone
IK
Inge Kehler
Program Head · Education
EmailPhone

Showing 9 of 67 verified contacts

Top roles at Immunic Therapeutics

49 distinct titles indexed · top 10 shown.

2medical director
2regulatory affairs manager
2senior clinical study lead
2vice president, global pharmaceutical development
1()
1,,,
1- - ä
1- ä ü
1-,
1associate clinical study lead
+39more titles

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 67 verified contacts at Immunic Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.